Lupardus P J, Wilke R A, Aydar E, Palmer C P, Chen Y, Ruoho A E, Jackson M B
Departments of Physiology, Medicine, Molecular Biology and Pharmacology, University of Wisconsin School of Medicine, 1300 University Avenue, Madison, WI 53706, USA.
J Physiol. 2000 Aug 1;526 Pt 3(Pt 3):527-39. doi: 10.1111/j.1469-7793.2000.00527.x.
Receptor-mediated modulation of ion channels generally involves G-proteins, phosphorylation, or both in combination. The sigma receptor, which modulates voltage-gated K+ channels, is a novel protein with no homology to other receptors known to modulate ion channels. In the present study patch clamp and photolabelling techniques were used to investigate the mechanism by which sigma receptors modulate K+ channels in peptidergic nerve terminals. The sigma receptor photoprobe iodoazidococaine labelled a protein with the same molecular mass (26 kDa) as the sigma receptor protein identified by cloning. The sigma receptor ligands pentazocine and SKF10047 modulated K+ channels, despite intra-terminal perfusion with GTP-free solutions, a G-protein inhibitor (GDPbetaS), a G-protein activator (GTPgammaS) or a non-hydrolysable ATP analogue (AMPPcP). Channels in excised outside-out patches were modulated by ligand, indicating that soluble cytoplasmic factors are not required. In contrast, channels within cell-attached patches were not modulated by ligand outside a patch, indicating that receptors and channels must be in close proximity for functional interactions. Channels expressed in oocytes without receptors were unresponsive to sigma receptor agonists, ruling out inhibition through a direct drug interaction with channels. These experiments indicate that sigma receptor-mediated signal transduction is membrane delimited, and requires neither G-protein activation nor protein phosphorylation. This novel transduction mechanism is mediated by membrane proteins in close proximity, possibly through direct interactions between the receptor and channel. This would allow for more rapid signal transduction than other ion channel modulation mechanisms, which in the present case of neurohypophysial nerve terminals would lead to the enhancement of neuropeptide release.
受体介导的离子通道调节通常涉及G蛋白、磷酸化或两者的结合。σ受体可调节电压门控钾通道,它是一种新型蛋白质,与已知调节离子通道的其他受体无同源性。在本研究中,采用膜片钳和光标记技术来研究σ受体调节肽能神经末梢钾通道的机制。σ受体光探针碘叠氮可卡因标记了一种与通过克隆鉴定的σ受体蛋白分子量相同(26 kDa)的蛋白质。尽管在末梢内灌注不含GTP的溶液、G蛋白抑制剂(GDPβS)、G蛋白激活剂(GTPγS)或不可水解的ATP类似物(AMPPcP),σ受体配体喷他佐辛和SKF10047仍能调节钾通道。切除的外向膜片中的通道受配体调节,这表明不需要可溶性细胞质因子。相反,在细胞贴附膜片内的通道在膜片外不受配体调节,这表明受体和通道必须紧密相邻才能发生功能相互作用。在没有受体的卵母细胞中表达的通道对σ受体激动剂无反应,排除了通过药物与通道直接相互作用产生抑制的可能性。这些实验表明,σ受体介导的信号转导是膜限定的,既不需要G蛋白激活也不需要蛋白质磷酸化。这种新型转导机制由紧密相邻的膜蛋白介导,可能是通过受体与通道之间的直接相互作用。这将比其他离子通道调节机制实现更快的信号转导,在本研究中,对于神经垂体神经末梢而言,这将导致神经肽释放增强。